IDiyas

For the Inventor, By the Inventor

Etoy, Switzerland

Patrick Gerber

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Villars-sous-Yens, CH (2009 - 2013)
  • Etoy, CH (2009 - 2016)

Company Filing History:

goldMedal9 out of 145 
 
Merck Serono S. A.
 patents
silverMedal2 out of 135 
 
Ares Trading S.a.
 patents
bronzeMedal2 out of 40 
 
Laboratoires Serono S.a.
 patents
4. 1 out of 10 
 
Laboratories Serono Sa
 patents

Years Active: 2009-2016

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 9403835 - Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators (2016-08-02),
2. 9216991 - Pyrimidine pyrazolyl derivatives (2015-12-22),
3. 8791142 - Oxazole pyridine derivatives useful as S1P1 receptor agonists (2014-07-29),
4. 8410110 - 9-(piperazinylalkyl) carbazoles as Bax-modulators (2013-04-02),
5. 8247437 - N-hydroxyamide derivatives and use thereof (2012-08-21),
6. 8202865 - Oxadiazole derivatives (2012-06-19),
7. 8053436 - 9-(piperazinylalkyl) carbazoles as bax-modulators (2011-11-08),
8. 8008302 - N-hydroxyamide derivatives and use thereof (2011-08-30),
9. 7973039 - Sulfonyl amino cyclic derivatives and use thereof (2011-07-05),
10. 7947851 - 1,1'-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors (2011-05-24),
11. 7879876 - Sulfonamide derivatives and use thereof for the modulation of metalloproteinases (2011-02-01),
12. 7696231 - Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) (2010-04-13),
13. 7592477 - Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) (2009-09-22),
14. 7589232 - Alkynyl aryl carboxamides (2009-09-15),

Title: **Patrick Gerber: A Trailblazer in Pharmaceutical Innovations**

Introduction

Patrick Gerber, a distinguished inventor based in Etoy, Switzerland, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 14 patents. His innovative work focuses on compounds that address various medical conditions, particularly through the modulation of biological pathways.

Latest Patents

Among his recent inventions is the patent for "Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators." This invention presents compounds designed as positive allosteric modulators for the M1 receptor, which plays a crucial role in treating diseases mediated by the muscarinic M1 mediator. Additionally, Gerber has developed "Pyrimidine pyrazolyl derivatives," which are aimed at treating serious conditions such as cancer and rheumatoid arthritis. These cutting-edge innovations showcase his dedication to addressing complex medical challenges through inventive solutions.

Career Highlights

Throughout his career, Patrick Gerber has held pivotal roles in renowned companies. Notably, he has worked with Merck Serono S.A., a global leader in biopharmaceuticals, and Ares Trading S.A., where he was able to translate his inventive ideas into practical applications that further the company's mission in the health sector.

Collaborations

Gerber's journey in innovation has been marked by collaborations with talented professionals such as Agnes Bombrun and Dominique Swinnen. These partnerships highlight the collaborative spirit of research and development within the pharmaceutical industry, enhancing the creativity and effectiveness of the projects they undertook.

Conclusion

As an inventor, Patrick Gerber stands out for his innovative contributions and unwavering commitment to improving health outcomes. His diverse portfolio of patents not only reflects his expertise but also his vision for the future of medicine. Through collaborations and significant career milestones, Gerber continues to inspire future generations of inventors in the pharmaceutical domain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…